✦ LIBER ✦

Comparison of the Effects of Methohexital and Propanidid on the Blood Pressure

Book ID: 115101003
Publisher: John Wiley and Sons
Year: 1965
Tongue: English
Weight: 105 KB
Volume: 9
Category: Article
ISSN: 0001-5172
DOI: 10.1111/j.1399-6576.1965.tb00614.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of Side Effects of Methohexit

Comparison of Side Effects of Methohexital and Thiopental With Propanidid

✍ J. W. Dundee 📂 Article 📅 1965 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

A controlled comparison of the psychotro

A controlled comparison of the psychotropic effects of propanidid and methohexitone

✍ Monica H. Greenwood; Malcolm H. Lader 📂 Article 📅 1974 🏛 Elsevier Science 🌐 English ⚖ 645 KB

Comparison of the Effects of Cilnidipine

Comparison of the Effects of Cilnidipine and Amldipine on Ambulatory Blood Pressure

✍ HOSHIDE, Satoshi; KARIO, Kazuomi; ISHIKAWA, Joji; EGUCHI, Kazuo; SHIMADA, Kazuyu 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB

Comparison of the intravenous reinforcin

Comparison of the intravenous reinforcing effects of propofol and methohexital in baboons

✍ Elise M Weerts; Nancy A Ator; Roland R Griffiths 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 213 KB

A comparison of the effects of sertralin

A comparison of the effects of sertraline and clomipramine on postural blood pressure changes and heart rate and blood pressure variability

✍ Coupland, N.J.; Wilson, S.J.; Bailey, J.E.; Potokar, J.; Nutt, D.J. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Comparison of the antihypertensive effec

Comparison of the antihypertensive effects of carvedilol and metoprolol on resting and exercise blood pressure

✍ Franz, I.-W. ;Agrawal, B. ;Wiewel, D. ;Ketelhut, R. 📂 Article 📅 1992 🏛 Springer-Verlag 🌐 English ⚖ 453 KB

The present study was conducted to assess the efficacy and safety of carvedilol 50 mg as compared to metoprolol 200 mg at rest and during and after a standardized bicycle ergometric exercise test. Carvedilol is a novel non-selective beta-blocker without intrinsic sympathomimetic activity possessing